Maurer, M.M.; Ibach, M.; Plewe, J.; Winter, A.; Ritschl, P.; Globke, B.; Öllinger, R.; Lurje, G.; Schöning, W.; Pratschke, J.;
et al. Reducing the Pill Burden: Immunosuppressant Adherence and Safety after Conversion from a Twice-Daily (IR-Tac) to a Novel Once-Daily (LCP-Tac) Tacrolimus Formulation in 161 Liver Transplant Patients. Biomedicines 2022, 10, 272.
https://doi.org/10.3390/biomedicines10020272
AMA Style
Maurer MM, Ibach M, Plewe J, Winter A, Ritschl P, Globke B, Öllinger R, Lurje G, Schöning W, Pratschke J,
et al. Reducing the Pill Burden: Immunosuppressant Adherence and Safety after Conversion from a Twice-Daily (IR-Tac) to a Novel Once-Daily (LCP-Tac) Tacrolimus Formulation in 161 Liver Transplant Patients. Biomedicines. 2022; 10(2):272.
https://doi.org/10.3390/biomedicines10020272
Chicago/Turabian Style
Maurer, Max M., Marius Ibach, Julius Plewe, Axel Winter, Paul Ritschl, Brigitta Globke, Robert Öllinger, Georg Lurje, Wenzel Schöning, Johann Pratschke,
and et al. 2022. "Reducing the Pill Burden: Immunosuppressant Adherence and Safety after Conversion from a Twice-Daily (IR-Tac) to a Novel Once-Daily (LCP-Tac) Tacrolimus Formulation in 161 Liver Transplant Patients" Biomedicines 10, no. 2: 272.
https://doi.org/10.3390/biomedicines10020272
APA Style
Maurer, M. M., Ibach, M., Plewe, J., Winter, A., Ritschl, P., Globke, B., Öllinger, R., Lurje, G., Schöning, W., Pratschke, J., & Eurich, D.
(2022). Reducing the Pill Burden: Immunosuppressant Adherence and Safety after Conversion from a Twice-Daily (IR-Tac) to a Novel Once-Daily (LCP-Tac) Tacrolimus Formulation in 161 Liver Transplant Patients. Biomedicines, 10(2), 272.
https://doi.org/10.3390/biomedicines10020272
